- Home
- IMCC vs PRPO Comparison
IMCC vs PRPO Comparison
Compare IMCC & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCC
- PRPO
- Stock Information
- Founded
- IMCC 1980
- PRPO N/A
- Country
- IMCC Israel
- PRPO United States
- Employees
- IMCC N/A
- PRPO N/A
- Industry
- IMCC Medicinal Chemicals and Botanical Products
- PRPO Biotechnology: Laboratory Analytical Instruments
- Sector
- IMCC Health Care
- PRPO Industrials
- Exchange
- IMCC Nasdaq
- PRPO Nasdaq
- Market Cap
- IMCC 12.2M
- PRPO 22.0M
- IPO Year
- IMCC N/A
- PRPO N/A
- Fundamental
- Price
- IMCC $1.96
- PRPO $18.41
- Analyst Decision
- IMCC
- PRPO
- Analyst Count
- IMCC 0
- PRPO 0
- Target Price
- IMCC N/A
- PRPO N/A
- AVG Volume (30 Days)
- IMCC 68.9K
- PRPO 16.4K
- Earning Date
- IMCC 11-13-2025
- PRPO 11-05-2025
- Dividend Yield
- IMCC N/A
- PRPO N/A
- EPS Growth
- IMCC N/A
- PRPO N/A
- EPS
- IMCC N/A
- PRPO N/A
- Revenue
- IMCC $38,430,631.00
- PRPO $21,242,000.00
- Revenue This Year
- IMCC $47.12
- PRPO N/A
- Revenue Next Year
- IMCC $12.83
- PRPO N/A
- P/E Ratio
- IMCC N/A
- PRPO N/A
- Revenue Growth
- IMCC 5.08
- PRPO 27.05
- 52 Week Low
- IMCC $1.29
- PRPO $3.90
- 52 Week High
- IMCC $7.12
- PRPO $22.38
- Technical
- Relative Strength Index (RSI)
- IMCC 48.61
- PRPO 53.40
- Support Level
- IMCC N/A
- PRPO N/A
- Resistance Level
- IMCC $2.03
- PRPO $22.38
- Average True Range (ATR)
- IMCC 0.24
- PRPO 1.31
- MACD
- IMCC -0.07
- PRPO -0.52
- Stochastic Oscillator
- IMCC 75.04
- PRPO 82.26
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.